UroGen Pharma (URGN) Enterprise Value (2017 - 2026)
UroGen Pharma's Enterprise Value came in at $1.69 billion for Q2 2026, up 255.4% from $475.99 million a year earlier and up 130.0% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Enterprise Value (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, UroGen Pharma reported Enterprise Value of $1.3 billion; for FY2025, it was $1.01 billion, up 375.4% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of 27.7% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $213.08 million in FY2024 (-39.2%), $350.53 million in FY2023 (+233.2%), $105.2 million in FY2022 (-15.7%) and $124.84 million in FY2021 (-58.1%).
- The Q2 2026 figure represents the highest quarterly Enterprise Value in data going back to Q2 2017.
- Year-over-year, Enterprise Value has increased for five consecutive quarters, with growth averaging 112.1% over the last eight quarters.
- The fastest year-over-year change in Enterprise Value over five years came in Q4 2025 (growth of 375.4%), and the weakest in Q1 2022 (a decline of 82.9%).
- Business Quant data shows URGN's Enterprise Value at $735.5 million (Q1 2026), $1.01 billion (Q4 2025) and $806.63 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | UroGen Pharma | 1.79 Bn | 1.29 Bn | 65.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.69 Bn |
| Mar 31, 2026 | 735.50 Mn |
| Dec 31, 2025 | 1.01 Bn |
| Sep 30, 2025 | 806.63 Mn |
| Jun 30, 2025 | 475.99 Mn |
| Mar 31, 2025 | 314.00 Mn |
| Dec 31, 2024 | 213.08 Mn |
| Sep 30, 2024 | 286.25 Mn |
| Jun 30, 2024 | 450.26 Mn |
| Mar 31, 2024 | 377.87 Mn |
| Dec 31, 2023 | 350.53 Mn |
| Sep 30, 2023 | 285.49 Mn |
| Jun 30, 2023 | 195.92 Mn |
| Mar 31, 2023 | 151.54 Mn |
| Dec 31, 2022 | 105.20 Mn |
| Sep 30, 2022 | 95.54 Mn |
| Jun 30, 2022 | 74.40 Mn |
| Mar 31, 2022 | 61.27 Mn |
| Dec 31, 2021 | 124.84 Mn |
| Sep 30, 2021 | 270.64 Mn |
API Access
UroGen Pharma Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();